Navigation Links
Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
Date:6/12/2008

DAYTON, Ohio, June 12 /PRNewswire-FirstCall/ -- Robbins & Myers, Inc. (NYSE: RBN) announced today that it will release its third quarter fiscal 2008 financial results for the period ended May 31, 2008, before the NYSE opens on Monday, June 30, 2008. A live webcast of the conference call is scheduled for June 30 at 11:00 a.m., EDT with Peter C. Wallace, President and Chief Executive Officer, and Christopher M. Hix, Vice President and Chief Financial Officer. They will discuss the Company's performance and respond to questions from the financial community.

Robbins & Myers invites interested investors to listen to the webcast, which will be broadcast live on its website http://www.robn.com . A webcast replay also will be available at the website and a telephonic replay will be available beginning 1:00 p.m., EDT on June 30, 2008 by dialing +1-888-286-8010 in the U.S. and entering conference ID # 63192398. The international replay number is +1-617-801-6888 with the same ID number.

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.


'/>"/>
SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Robbins & Myers Reports Additional Gain and Increases Earnings Guidance
2. Robbins & Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call
3. Robbins & Myers to Present at Gabelli Conference
4. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
5. Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
6. Robbins Bros. Gives Water at AIDS Walk L.A.
7. Robbins & Myers Announces Regular Quarterly Cash Dividend
8. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
9. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
10. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
11. Bristol-Myers Squibb to Announce Results for the First Quarter of 2008 on April 24
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 2Top 5 Global Spinal Implant Companies Maintaining Position but Competition Rising Rapidly 3Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Cephalon Quarterly Conference Call Invitation 12853 1Police work undermines cardiovascular health comparison to general population shows 50430 1Police work undermines cardiovascular health comparison to general population shows 50430 2Police work undermines cardiovascular health comparison to general population shows 50430 3Bladder Cancer No Longer a Death Sentence 50427 1Bladder Cancer No Longer a Death Sentence 50427 2Bladder Cancer No Longer a Death Sentence 50427 3